Cas:1197193-26-2 4-(4-methylpiperazin-1-yl)-2-methylsulfonylbenzaldehyde manufacturer & supplier

Chemical Name:4-(4-methylpiperazin-1-yl)-2-methylsulfonylbenzaldehyde

CAS.NO:1197193-26-2

Synonyms:4-(4-methyl-1-piperazinyl)-2-(methylsulfonyl)benzaldehyde;4-(4-methylpiperazin-1-yl)-2-(methylsulfonyl)benzaldehyde

Molecular Formula:C₁₃H₁₈N₂O₃S

Molecular Weight:282.35900

HS Code:2933599090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:66.07000

Exact Mass:282.10400

LogP:1.73810

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-(4-methyl-1-piperazinyl)-2-(methylsulfonyl)benzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(4-methylpiperazin-1-yl)-2-(methylsulfonyl)benzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(4-methylpiperazin-1-yl)-2-(methylsulfonyl)benzaldehyde Use and application,4-(4-methyl-1-piperazinyl)-2-(methylsulfonyl)benzaldehyde technical grade,usp/ep/jp grade.

Related News: Villages and cities in China have resorted to flying drones with speakers to patrol streets and scold people not wearing masks in public amid the coronavirus outbreak, according to Chinese state media. 4-(4-methylpiperazin-1-yl)-2-methylsulfonylbenzaldehyde manufacturer Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space. 4-(4-methylpiperazin-1-yl)-2-methylsulfonylbenzaldehyde supplier Villages and cities in China have resorted to flying drones with speakers to patrol streets and scold people not wearing masks in public amid the coronavirus outbreak, according to Chinese state media. 4-(4-methylpiperazin-1-yl)-2-methylsulfonylbenzaldehyde vendor China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug. 4-(4-methylpiperazin-1-yl)-2-methylsulfonylbenzaldehyde factory In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company.